Target intelligence / Profile preview

Cartilage regeneration via autologous chondrocyte implantation on biocompatible scaffold

Molecular classification
Other
01

Overview

"Cartilage regeneration via autologous chondrocyte implantation on biocompatible scaffold" refers to a surgical technology used to repair focal defects in articular cartilage, especially of the knee. In this procedure, a patient’s own cartilage cells (chondrocytes) are harvested, expanded in vitro, and implanted into the cartilage defect, often using a biocompatible scaffold to enhance cell retention and support cartilage regeneration. There are several generations of this technique, including matrix-induced autologous chondrocyte implantation (MACI), which uses a collagen or synthetic matrix to deliver the cells. The primary goal is to generate new hyaline-like cartilage to restore function and decrease symptoms in people with isolated cartilage injuries[1][3][6][9]. While not a molecular target itself, the procedure acts on cartilage through biological repair and cellular proliferation.

Other names
Autologous chondrocyte implantationACIMatrix-induced autologous chondrocyte implantation (MACI)Cartilage tissue engineering via chondrocyte implantationCartilage regeneration by ACI
02

Mechanism of action

Surgical delivery of expanded autologous chondrocytes to cartilage defects Support of cell attachment/growth by biocompatible scaffold Promotion of hyaline-like or fibrocartilage regeneration[1][6][9]

03

Biological functions

Cartilage repairTissue regenerationCell proliferation (specifically chondrocytes)
04

Disease associations

Osteochondral defectOsteoarthritisArticular cartilage injury
05

Safety considerations

Hypertrophy of the repair tissue (overgrowth)Procedure-related infectionGraft failure over long termTechnical surgical challenges
06

Biomarkers

None specific to the procedure (MRI, histology, or cartilage matrix markers such as Collagen II, Aggrecan, used for evaluating engraftment)

Beyond the preview

Go deeper on Cartilage regeneration via autologous chondrocyte implantation on biocompatible scaffold.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cartilage regeneration via autologous chondrocyte implantation on biocompatible scaffold.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call